NasdaqCM:CPRXBiotechs
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Firdapse Momentum And Growing Agamree Contribution
Stock move and what sparked it
Catalyst Pharmaceuticals (CPRX) drew attention after a 6.7% share price move in the last session on higher trading volume, as investors focused on Firdapse momentum, Agamree uptake, and upcoming earnings expectations.
See our latest analysis for Catalyst Pharmaceuticals.
That 6.7% move came on top of a 16.97% 30 day share price return and an 18.23% year to date share price return, while total shareholder return over five years has been very large, suggesting...